Categories
Connect with us on LinkedIn
Early-stage biotech’s AI advantage is a window that closes. Sol Babani and Derk Arts on how to use it.
Sol Babani and Derk Arts on why early-stage biotech must build AI-native operations, not retrofit old ones. Decision...
Building a Safer, Smarter Future: A Tiered Approach to AI in Life Sciences
Adopt AI in clinical research with confidence using a risk-based framework that ensures privacy, security, and regulatory alignment.
Do We Still Need Patients in Tomorrow’s Trials? Modeling Placebo Effect and Beyond
Discover the transformative role of AI in clinical trials, with expert insights from Derk Arts and MaryAnne Rizk...
